RxDoctor Payments Data

John Stringfield, MD

Family Medicine · Waynesville, NCNPI 1356435465

Payments from drug & device makers

$347in general payments, 2019–2025

Across 22 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$78
  • Abbott$70
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$59
  • Amgen$31
  • Corium, LLC$20
  • Amarin Pharma, Inc.$18
  • plus $71 from 5 others

What the payments were for

  • Food & beverage$347100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$347 in reported general payments places this provider in the 50th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$69,332
Medicare patients
297
Services billed
720

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban443$173,255
XareltoRivaroxaban109$51,012
OzempicSemaglutide37$45,072
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$41,068
JardianceEmpagliflozin78$40,958
FarxigaDapagliflozin Propanediol46$39,283
Breo ElliptaFluticasone/Vilanterol62$33,933
MyrbetriqMirabegron55$20,102
InvokanaCanagliflozin20$18,247
LinzessLinaclotide31$17,956
Spiriva RespimatTiotropium Bromide19$11,629
Tiotropium Bromide18$9,095
Atrovent HfaIpratropium Bromide16$8,777
TrulicityDulaglutide11$8,427
EntrestoSacubitril/Valsartan18$7,838

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$13$78,957126 claims
Novo NordiskOzempic$12$45,07237 claims
Astellas Pharma US IncMyrbetriq$18$20,10255 claims
AbbVieLinzess$78$17,95631 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Waynesville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →